Cargando…

The Role of Adjuvant Hormonal Treatment after Surgery for Localized High-Risk Prostate Cancer: Results of a Matched Multiinstitutional Analysis

Introduction. To assess the role of adjuvant androgen deprivation therapy (ADT) in high-risk prostate cancer patients (PCa) after surgery. Materials and Methods. The analysis case matched 172 high-risk PCa patients with positive section margins or non-organ confined disease and negative lymph nodes...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schubert, Maria, Joniau, Steven, Gontero, Paolo, Kneitz, Susanne, Scholz, Claus-Jürgen, Kneitz, Burkhard, Briganti, Alberto, Karnes, R. Jeffrey, Tombal, Bertrand, Walz, Jochen, Hsu, Chao-Yu, Marchioro, Giansilvio, Bader, Pia, Bangma, Chris, Frohneberg, Detlef, Graefen, Markus, Schröder, Fritz, van Cangh, Paul, van Poppel, Hein, Spahn, Martin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3286887/ https://www.ncbi.nlm.nih.gov/pubmed/22400018 http://dx.doi.org/10.1155/2012/612707

Ejemplares similares

Preoperative Risk-Stratification of High-Risk Prostate Cancer: A Multicenter Analysis
por: Chys, Brecht, et al.
Publicado: (2020)

Impact of Lymph Node Burden on Survival of High-risk Prostate Cancer Patients Following Radical Prostatectomy and Pelvic Lymph Node Dissection
por: Moris, Lisa, et al.
Publicado: (2016)

Distinct microRNA Expression Profile in Prostate Cancer Patients with Early Clinical Failure and the Impact of let-7 as Prognostic Marker in High-Risk Prostate Cancer
por: Schubert, Maria, et al.
Publicado: (2013)

MiR-205 Is Progressively Down-Regulated in Lymph Node Metastasis but Fails as a Prognostic Biomarker in High-Risk Prostate Cancer
por: Kalogirou, Charis, et al.
Publicado: (2013)

What is the Need for Prostatic Biomarkers in Prostate Cancer Management?
por: Spahn, Martin, et al.
Publicado: (2015)

Sense and Nonsense of an Extended Pelvic Lymph Node Dissection in Prostate Cancer
por: Van Baelen, Anthony, et al.
Publicado: (2012)

Ki-67, topoisomerase IIα and miR-221 have a limited prostate cancer risk stratification ability on a medium-term follow-up: results of a high-risk radical prostatectomy cohort
por: Marra, Giancarlo, et al.
Publicado: (2022)

Combination of expression levels of miR-21 and miR-126 is associated with cancer-specific survival in clear-cell renal cell carcinoma
por: Vergho, Daniel, et al.
Publicado: (2014)

High expression of Sterol-O-Acyl transferase 1 (SOAT1), an enzyme involved in cholesterol metabolism, is associated with earlier biochemical recurrence in high risk prostate cancer
por: Eckhardt, Carolin, et al.
Publicado: (2021)

Oncological and functional efficacy of nephron-sparing surgery versus radical nephrectomy in renal cell carcinoma stages ≥cT1b: a single institution, matched analysis
por: Veys, Ralf, et al.
Publicado: (2017)

Cardiovascular risk during hormonal treatment in patients with prostate cancer
por: Van Poppel, Hein, et al.
Publicado: (2011)

Impact of miR-21, miR-126 and miR-221 as Prognostic Factors of Clear Cell Renal Cell Carcinoma with Tumor Thrombus of the Inferior Vena Cava
por: Vergho, Daniel Claudius, et al.
Publicado: (2014)

DNA Methylation-Guided Prediction of Clinical Failure in High-Risk Prostate Cancer
por: Litovkin, Kirill, et al.
Publicado: (2015)

Impact of Novel Multiinstitutional Curriculum on Critical Care Fellow Ventilator Knowledge
por: Seam, Nitin, et al.
Publicado: (2020)

Loss of tumor suppressor mir-203 mediates overexpression of LIM and SH3 Protein 1 (LASP1) in high-risk prostate cancer thereby increasing cell proliferation and migration
por: Hailer, Amelie, et al.
Publicado: (2014)

miR-221 Augments TRAIL-Mediated Apoptosis in Prostate Cancer Cells by Inducing Endogenous TRAIL Expression and Targeting the Functional Repressors SOCS3 and PIK3R1
por: Krebs, Markus, et al.
Publicado: (2019)

A Giant Mucinous Adenocarcinoma Arising within a Villous Adenoma of the Urachus: Case Report and Review of the Literature
por: Joniau, Steven, et al.
Publicado: (2009)

Inflammatory complications of vocal fold injection with hyaluronic acid: a multiinstitutional study
por: ENVER, Necat, et al.
Publicado: (2021)

miR-221-3p Regulates VEGFR2 Expression in High-Risk Prostate Cancer and Represents an Escape Mechanism from Sunitinib In Vitro
por: Krebs, Markus, et al.
Publicado: (2020)

Oligometastatic prostate cancer: Metastases-directed therapy?
por: Van Poppel, Hein, et al.
Publicado: (2016)

Open Surgery for Localized RCC
por: Vander Eeckt, Kathy, et al.
Publicado: (2007)

Five-Year Subjective Outcomes of Obstructive Sleep Apnea Surgery: A Multiinstitutional Study
por: Choi, Ji Ho, et al.
Publicado: (2015)

Clinical outcomes and costs of robotic surgery in prostate cancer: a multiinstitutional study in Korea
por: Yun, Ji Eun, et al.
Publicado: (2019)

Somatic Hypermutation in Muts Homologue (Msh)3-, Msh6-, and Msh3/Msh6-Deficient Mice Reveals a Role for the Msh2–Msh6 Heterodimer in Modulating the Base Substitution Pattern
por: Wiesendanger, Margrit, et al.
Publicado: (2000)

Chemoprevention of prostate cancer with nutrients and supplements
por: Van Poppel, Hendrik, et al.
Publicado: (2011)

Metabolic Changes after Urinary Diversion
por: Van der Aa, Frank, et al.
Publicado: (2011)

The long-term outcomes of alternating chemoradiotherapy for locoregionally advanced nasopharyngeal carcinoma: a multiinstitutional phase II study
por: Fuwa, Nobukazu, et al.
Publicado: (2015)

Surveillance as an Option for the Treatment of Small Renal Masses
por: Klaver, S., et al.
Publicado: (2008)

Renal Cell Carcinoma with Synchronous Metastasis to the Calcaneus and Metachronous Metastases to the Ovary and Gallbladder
por: Decoene, Jasper, et al.
Publicado: (2011)

Infektionsprophylaxe bei rheumatologischen Erkrankungen
por: Kneitz, Christian, et al.
Publicado: (2020)

Prostatic urethral length as a predictive factor for surgical treatment of benign prostatic hyperplasia: a prospective, multiinstitutional study
por: Kim, Bum Soo, et al.
Publicado: (2019)

Efficacy and safety of cabazitaxel therapy in elderly (≥75 years) patients with castration-resistant prostate cancer: A multiinstitutional study
por: Matsumoto, Takashi, et al.
Publicado: (2021)

The Interleukin 2 Receptor α Chain/CD25 Promoter Is a Target for Nuclear Factor of Activated T Cells
por: Schuh, Kai, et al.
Publicado: (1998)

Prognostic impact of CRTC1/3‐MAML2 fusions in salivary gland mucoepidermoid carcinoma: A multiinstitutional retrospective study
por: Okumura, Yoshihide, et al.
Publicado: (2020)

Wichtigste Impfungen bei Patienten mit rheumatologischen Erkrankungen und warum
por: Kneitz, C., et al.
Publicado: (2020)

A new method for determination of varicella-zoster virus immunoglobulin G avidity in serum and cerebrospinal fluid
por: Kneitz, Ralf-Herbert, et al.
Publicado: (2004)

Radical Prostatectomy and Intraoperative Radiation Therapy in High-Risk Prostate Cancer
por: Marchioro, Giansilvio, et al.
Publicado: (2012)

Low frequency of p16(INK4a) promoter methylation in mammary carcinomas as revealed by positive display of methylated sites
por: Lilischkis, R, et al.
Publicado: (2000)

CD10-Positive Cutaneous PEComa: An Extremely Rare Skin Tumour
por: Ueberschaar, Simon, et al.
Publicado: (2020)

Uro-oncology in the era of social distancing: the principles of patient-centered online consultations during the COVID-19 pandemic
por: Sosnowski, Roman, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_0f61k7us1ivgp81bu0s9vpp0d0